ORGN News & Events

Origin Materials announced an organizational realignment and cost containment measures reflecting proactive steps to enhance its cash and capital resources dedicated to PET cap commercialization to allow Origin to achieve adjusted EBITDA run-rate breakeven in 2027. Steps to enhance cash resources include: reduced annual operating expenditures from approximately $40M to a projected $29M by reducing headcount, indefinitely suspending furanics platform development expenses, and focusing the scope of 2026 new format development; the company anticipates that it will incur approximately $0.9M in restructuring charges in connection with the workforce reduction, primarily consisting of cash expenditures of approximately $0.9M for severance and benefits costs; limiting our CapFormer line build-out in 2026 to the six lines already fully procured and projected to be installed by end of year; we expect these cost reductions will substantially reduce Origin's forward financing requirements to reach profitability; position origin to access additional tranches of the previously announced $100M debt facility, as needed. The company believes this debt facility can serve near-term working capital requirements, provided our prospective customers qualify our pressurized water cap in the expected timeframe. "We are closer now than ever before to successful delivery of our PET caps to multiple world-class beverage brands. It has taken us longer to reach this point than expected, which we believe has not had a negative impact on the strong interest in our product but has negatively impacted our stock price and consumed more resources than projected," said Origin CEO John Bissell. "Therefore, we've taken a number of necessary, and non-dilutive measures to enhance our cash resources and reduce the amount of additional capital we require to achieve cash-positive operations, while maintaining the required expertise and horsepower to successfully commercialize our PET caps in 2026. We estimate that we've reduced our operating expenses by approximately 25% by both ceasing further investments in our furanics platform, narrowing our PET cap format development initiatives in 2026 by deferring non-beverage cap format development to 2027, and limiting our CapFormer line build-out in 2026 to the six lines already fully procured and scheduled to be installed by end of year. With these measures in place, which include reduction in headcount, and continued successful execution of our plan, we expect our previously announced convertible debt and equipment debt financing arrangements to provide the necessary working capital to fund operations to achieve Adjusted EBITDA run-rate breakeven in 2027."

Origin Materials has entered into binding agreements to settle the shareholder class action lawsuit and the related derivative lawsuit pending in the United States District Court for the Eastern District of California. The proposed settlements resolve all claims asserted against Origin and the other named defendants in the lawsuits, without any liability or wrongdoing attributed to them or the company. The shareholder class action lawsuit and related derivative lawsuit were initially filed in August 2023 and March respectively.

Origin Materials and Royal Hordijk Packaging announced a strategic partnership to mass produce PET bottlecaps.

Bissell added: "As we stand up manufacturing, continuous improvement is the rule." Forthcoming lines are expected to incorporate Origin design modifications to increase throughput and result in superior unit economics. To reiterate and expand on our previous guidance: we expect gross margins for caps in the mid double-digits and capital cost per line to end up in the mid-single digit millions. To further improve margins, we may also choose to acquire PET extruders for installations where we believe vertical integration is optimal versus renting extrusion or purchasing sheet from our manufacturing partners. We anticipate the payback period for the average CapFormer line, separate from any extruders, to be less than 18 months. We plan to stand up additional Origin CapFormer lines at a roughly similar pace to our 2025 deployment in 2026, accelerating as capital allows. We also expect full-year 2026 revenue of $110M to $140M, separate from potential licensing revenue."